Host genetics and outcome in meningococcal disease: a systematic review and meta-analysis (Q37718321)

22 August 2017

0 references

1 reference

title

Host genetics and outcome in meningococcal disease: a systematic review and meta-analysis (English)

1 reference

22 August 2017

0 references

1 reference

meningococcal disease

1 reference

1 reference

Robert C Read

0 references

Diederik van de Beek

0 references

Matthijs C Brouwer

1 reference

22 August 2017

publication date

1 April 2010

1 reference

Lancet Infectious Diseases

22 August 2017

published in

1 reference

22 August 2017

1 reference

22 August 2017

1 reference

22 August 2017

page(s)

262-274

1 reference

22 August 2017

cites work

Meningococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970045-1

7 January 2021

Epidemic meningitis, meningococcaemia, and Neisseria meningitidis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970045-1

7 January 2021

Host genetic susceptibility to pneumococcal and meningococcal disease: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970045-1

7 January 2021

Endotoxin release and cytokine production in acute and chronic meningococcaemia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970045-1

7 January 2021

Clinical features, outcome, and meningococcal genotype in 258 adults with meningococcal meningitis: a prospective cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970045-1

7 January 2021

Severity of meningococcal disease associated with genomic bacterial load

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970045-1

7 January 2021

Variation within genes encoding interleukin-1 and the interleukin-1 receptor antagonist influence the severity of meningococcal disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970045-1

7 January 2021

Prognostic factors in meningococcal disease. Development of a bedside predictive model and scoring system. Barcelona Meningococcal Disease Surveillance Group

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970045-1

7 January 2021

Acute meningococcal meningitis: analysis of features of the disease according to the age of 255 patients. Copenhagen Meningitis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970045-1

7 January 2021

Clinical manifestations and course of meningococcal disease in 562 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970045-1

7 January 2021

Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970045-1

7 January 2021

The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970045-1

7 January 2021

Purpura fulminans in meningococcemia: association with acquired deficiencies of proteins C and S.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970045-1

7 January 2021

Bidirectional relation between inflammation and coagulation

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970045-1

7 January 2021

The immunopathogenesis of sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970045-1

7 January 2021

Update on meningococcal disease with emphasis on pathogenesis and clinical management

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970045-1

7 January 2021

Genetic influence on cytokine production and fatal meningococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970045-1

7 January 2021

4G/5G promoter polymorphism in the plasminogen-activator-inhibitor-1 gene and outcome of meningococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970045-1

7 January 2021

Variation in the tumor necrosis factor-alpha gene promoter region may be associated with death from meningococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970045-1

7 January 2021

Genetic influence on cytokine production in meningococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970045-1

7 January 2021

Genomic polymorphic profiles in an Irish population with meningococcaemia: is it possible to predict severity and outcome of disease?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970045-1

7 January 2021

A functional polymorphism of toll-like receptor 4 is not associated with likelihood or severity of meningococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970045-1

7 January 2021

Association of variants of the gene for mannose-binding lectin with susceptibility to meningococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970045-1

7 January 2021

Age-dependent association of human mannose-binding lectin mutations with susceptibility to invasive meningococcal disease in childhood

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970045-1

7 January 2021

Associations between Fc gamma receptor IIA polymorphisms and the risk and prognosis of meningococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970045-1

7 January 2021

Relevance of genetically determined host factors to the prognosis of meningococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970045-1

7 January 2021

FcγRIIa and FcγRIIIb polymorphisms were not associated with meningococcal disease in Western Norway

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970045-1

7 January 2021

Polymorphisms in the Interleukin-1 Gene Cluster in Children and Young Adults with Systemic Meningococcemia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970045-1

7 January 2021

Variable number tandem repeat polymorphism of the interleukin-1 receptor antagonist gene in meningococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970045-1

7 January 2021

The tumor necrosis factor polymorphism TNF (-308) is associated with susceptibility to meningococcal sepsis, but not with lethality

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970045-1

7 January 2021

Variation in plasminogen-activator-inhibitor-1 gene and risk of meningococcal septic shock

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970045-1

7 January 2021

Role of functional plasminogen-activator-inhibitor-1 4G/5G promoter polymorphism in susceptibility, severity, and outcome of meningococcal disease in Caucasian children*

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970045-1

7 January 2021

4G/5G promoter polymorphism in the plasminogen-activator-inhibitor-1 gene in children with systemic meningococcaemia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970045-1

7 January 2021

A functional single nucleotide polymorphism in the thrombin-activatable fibrinolysis inhibitor (TAFI) gene associates with outcome of meningococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970045-1

7 January 2021

Effect of the Factor V Leiden mutation on the severity of meningococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970045-1

7 January 2021

Genetic polymorphism of the binding domain of surfactant protein-A2 increases susceptibility to meningococcal disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970045-1

7 January 2021

Severity of Meningococcal Disease in Children and the Angiotensin-Converting Enzyme Insertion/Deletion Polymorphism

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970045-1

7 January 2021

Association of human Fc gamma RIIa (CD32) polymorphism with susceptibility to and severity of meningococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970045-1

7 January 2021

Fc gamma receptor IIa (CD32) polymorphism in fulminant meningococcal septic shock in children

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970045-1

7 January 2021

4G4G genotype of the plasminogen activator inhibitor-1 promoter polymorphism associates with disseminated intravascular coagulation in children with systemic meningococcemia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970045-1

7 January 2021

Protein C promoter polymorphisms associate with sepsis in children with systemic meningococcemia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970045-1

7 January 2021

Single nucleotide polymorphisms in genes of circulatory homeostasis in surviving pediatric intensive care patients with meningococcal infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970045-1

7 January 2021

Relevance of Fcgamma receptor and interleukin-10 polymorphisms for meningococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970045-1

7 January 2021

Prognosis of meningococcal septicaemia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970045-1

7 January 2021

Validation of the Glasgow Meningococcal Septicemia Prognostic Score: a 10-year retrospective survey

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970045-1

7 January 2021

Prospective validation of the Glasgow Meningococcal Septicaemia Prognostic Score. Comparison with other scoring methods

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970045-1

7 January 2021

Comparison of two different severity scores (Paediatric Risk of Mortality [PRISM] and the Glasgow Meningococcal Sepsis Prognostic Score [GMSPS]) in meningococcal disease: preliminary analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970045-1

7 January 2021

Comparison of the performance of two general and three specific scoring systems for meningococcal septic shock in children

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970045-1

7 January 2021

Meningococcal disease: a comparison of eight severity scores in 125 children

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970045-1

7 January 2021

Can generic scores (Pediatric Risk of Mortality and Pediatric Index of Mortality) replace specific scores in predicting the outcome of presumed meningococcal septic shock in children?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970045-1

7 January 2021

Pediatric risk of mortality (PRISM) score in meningococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970045-1

7 January 2021

Factor H, a regulator of complement activity, is a major determinant of meningococcal disease susceptibility in UK Caucasian patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970045-1

7 January 2021

Role of Toll-like receptors in infection and immunity: clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970045-1

7 January 2021

Single nucleotide polymorphisms of Toll-like receptors and susceptibility to infectious disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970045-1

7 January 2021

Clinical manifestations of mannan-binding lectin deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970045-1

7 January 2021

Neisseria meningitidis: an overview of the carriage state

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970045-1

7 January 2021

FcgammaR polymorphisms: Implications for function, disease susceptibility and immunotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970045-1

7 January 2021

Plasminogen activator inhibitor type 1 gene polymorphism and sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970045-1

7 January 2021

The quantitative association of plasma endotoxin, antithrombin, protein C, extrinsic pathway inhibitor and fibrinopeptide A in systemic meningococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970045-1

7 January 2021

Two Mutations in the Promoter Region of the Human Protein C Gene Both Cause Type I Protein C Deficiency by Disruption of Two HNF-3 Binding Sites

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970045-1

7 January 2021

Clinical trials in severe sepsis with drotrecogin alfa (activated)

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970045-1

7 January 2021

Activated protein C in sepsis: a critical review

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970045-1

7 January 2021

Drotrecogin alfa (activated) in patients with severe sepsis presenting with purpura fulminans, meningitis, or meningococcal disease: a retrospective analysis of patients enrolled in recent clinical studies

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970045-1

7 January 2021

Activation of protein C following infusion of protein C concentrate in children with severe meningococcal sepsis and purpura fulminans: a randomized, double-blinded, placebo-controlled, dose-finding study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970045-1

7 January 2021

Fulminant sepsis/meningitis due to Haemophilus influenzae in a protein C-deficient heterozygote treated with activated protein C therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970045-1

7 January 2021

A case of purpura fulminans is caused by homozygous delta8857 mutation (protein C-nagoya) and successfully treated with activated protein C concentrate

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970045-1

7 January 2021

Recombinant bactericidal/permeability-increasing protein (rBPI21) as adjunctive treatment for children with severe meningococcal sepsis: a randomised trial. rBPI21 Meningococcal Sepsis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970045-1

7 January 2021

Randomized, placebo-controlled trial of HA-1A, a human monoclonal antibody to endotoxin, in children with meningococcal septic shock. European Pediatric Meningococcal Septic Shock Trial Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970045-1

7 January 2021

A surveillance network for meningococcal disease in Europe.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970045-1

7 January 2021

Naturally occurring lipid A mutants in neisseria meningitidis from patients with invasive meningococcal disease are associated with reduced coagulopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970045-1

7 January 2021

Reporting, appraising, and integrating data on genotype prevalence and gene-disease associations

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970045-1

7 January 2021

Problems of reporting genetic associations with complex outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970045-1

7 January 2021

Biobanking for Europe

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970045-1

7 January 2021

10.1016/S1473-3099(10)70045-1

Identifiers

DOI

1 reference

22 August 2017

1 reference